Theoretical effects on years of life free of AD and all-cause dementia per a Q5 to Q1 difference in RBC DHA were compared with the estimated effects of age (per 1 year older at baseline) and APOE-ε4 (compared with non-carriers) (Table 6). The gene discussed is APOE; the disease is Alzheimer disease.